Tuberculosis is a widespread infectious disease caused by mycobacteria that typically affects the lungs. It spreads through airborne droplets when infected people cough, sneeze or speak. Symptoms include fever, night sweats, and weight loss. While most infections are latent and asymptomatic, active disease can be fatal if left untreated. Tuberculosis is treated with a combination of antibiotics taken for at least six months.
Pulmonary TB is a bacterial infection of the lungs that can cause a range of symptoms, including chest pain, breathlessness, and severe coughing. Pulmonary TB can be life-threatening if a person does not receive treatment. People with active TB can spread the bacteria through the air.
Pulmonary TB is a bacterial infection of the lungs that can cause a range of symptoms, including chest pain, breathlessness, and severe coughing. Pulmonary TB can be life-threatening if a person does not receive treatment. People with active TB can spread the bacteria through the air.
Typhoid fever, also known as enteric fever, is a potentially fatal multisystemic illness caused primarily by Salmonella enterica, subspecies enterica serovar typhi and, to a lesser extent, related serovars paratyphi A, B, and C.
The protean manifestations of typhoid fever make this disease a true diagnostic challenge. The classic presentation includes fever, malaise, diffuse abdominal pain, and constipation. Untreated, typhoid fever is a grueling illness that may progress to delirium, obtundation, intestinal hemorrhage, bowel perforation, and death within 1 month of onset. Survivors may be left with long-term or permanent neuropsychiatric complications.
This powerpoint, deals with HIV pathophysiology, signs and symptoms, mode of transmission and diagnostic parameters.
Purely based on clinical pharmacist perspective.
Pertussis : Highly contagious respiratory infection caused by Bordetella pertussis
Outbreaks first described in 16th century
Bordetella pertussis isolated in 1906
Estimated >300,000 deaths annually worldwide
Before the availability of pertussis vaccine in the 1940s, public health experts reported more than 200,000 cases of pertussis annually.
Since widespread use of the vaccine began, incidence has decreased more than 75% compared with the pre-vaccine era.
In 2012, the last peak year, CDC reported 48,277 cases of pertussis.
Extremely contagious-attack rate 100%
Immunity is never complete
Protection begins to wane in 3-5 yrs after vaccination
Typhoid fever, also known as enteric fever, is a potentially fatal multisystemic illness caused primarily by Salmonella enterica, subspecies enterica serovar typhi and, to a lesser extent, related serovars paratyphi A, B, and C.
The protean manifestations of typhoid fever make this disease a true diagnostic challenge. The classic presentation includes fever, malaise, diffuse abdominal pain, and constipation. Untreated, typhoid fever is a grueling illness that may progress to delirium, obtundation, intestinal hemorrhage, bowel perforation, and death within 1 month of onset. Survivors may be left with long-term or permanent neuropsychiatric complications.
This powerpoint, deals with HIV pathophysiology, signs and symptoms, mode of transmission and diagnostic parameters.
Purely based on clinical pharmacist perspective.
Pertussis : Highly contagious respiratory infection caused by Bordetella pertussis
Outbreaks first described in 16th century
Bordetella pertussis isolated in 1906
Estimated >300,000 deaths annually worldwide
Before the availability of pertussis vaccine in the 1940s, public health experts reported more than 200,000 cases of pertussis annually.
Since widespread use of the vaccine began, incidence has decreased more than 75% compared with the pre-vaccine era.
In 2012, the last peak year, CDC reported 48,277 cases of pertussis.
Extremely contagious-attack rate 100%
Immunity is never complete
Protection begins to wane in 3-5 yrs after vaccination
Tuberculosis, MTB or TB, which was formerly known as “Consumption”, “Phthisis
pulmonalis”, is an infectious bacterial disease that is caused by mycobacteria
mainly by “Mycobacterium tuberculosis”. Lungs are the main site of infection in
the tuberculosis, but other systems of the body are also infected. Tuberculosis
spread through air droplets from a person who has active disease through
respiratory system.
Tuberculosis (TB) is an infectious disease usually caused by Mycobacterium tuberculosis (MTB) bacteria. Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections show no symptoms, in which case it is known as latent tuberculosis.
TB is spread from person to person through the air. When people with lung TB cough, sneeze or spit, they propel the TB germs into the air. A person needs to inhale only a few of these germs to become infected.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
2. Tuberculosis,TB also called phthisis, phthisis
pulmonalis, or consumption, is a widespread,
and in many cases fatal, infectious
disease caused by various strains
of mycobacteria, usually Mycobacterium
tuberculosis. Tuberculosis typically attacks
the lungs, but can also affect other parts of
the body.
3. Mode of infection
It is spread through the air when people who have
an active TB infection cough, sneeze, or otherwise
transmit respiratory fluids through the air. Most
infections do not have symptoms, known as latent
tuberculosis. About one in ten latent infections
eventually progresses to active disease which, if
left untreated, kills more than 50% of those so
infected.
4. When people with active pulmonary TB cough,
sneeze, speak, sing, or spit, they expel
infectious aerosol droplets 0.5 to 5.0 μm in
diameter. A single sneeze can release up to
40,000 droplets. Each one of these droplets
may transmit the disease, since the infectious
dose of tuberculosis is very small (the
inhalation of fewer than 10 bacteria may
cause an infection)
5. Types of TB
Tuberculosis is divided into two
categories: pulmonary and extrapulmonary.
Pulmonary Tuberculosis Types:
Primary Tuberculosis Pneumonia
Tuberculosis Pleurisy
Cavitary Tuberculosis
Miliary TB
Laryngeal Tuberculosis
6. Primary Tuberculosis Pneumonia
This uncommon type of TB presents as
pneumonia and is very infectious. Patients have a
high fever and productive cough. It occurs most
often in extremely young children and the elderly. It
is also seen in patients with immunosuppression,
such as people with HIV/AIDS, and in patients on
long term corticosteroid therapy.
7. Tuberculosis Pleurisy
This usually develops soon after initial infection. A granuloma
located at the edge of the lung ruptures into the pleural space,
the space between the lungs and the chest wall. Usually, a couple
of tablespoons of fluid can be found in the pleural space.
Once the bacteria invade the space, the amount of fluid increases
dramatically and compresses the lung, causing shortness of
breath (dyspnea) and sharp chest pain that worsens with a deep
breath (pleurisy). A chest x-ray shows significant amounts of
fluid. Mild- or low-grade fever commonly is present. Tuberculosis
pleurisy generally resolves without treatment; however, two-thirds
of patients with tuberculosis pleurisy develop active
pulmonary TB within 5 years.
8.
9. Cavitary TB
Cavitary TB involves the upper lobes of the lung. The bacteria
cause progressive lung destruction by forming cavities, or
enlarged air spaces. This type of TB occurs in reactivation disease.
The upper lobes of the lung are affected because they are highly
oxygenated (an environment in which M. tuberculosis thrives).
Cavitary TB can, rarely, occur soon after primary infection.
Symptoms include productive cough, night sweats, fever, weight
loss, and weakness. There may be hemoptysis (coughing up
blood). Patients with cavitary TB are highly contagious.
Occasionally, disease spreads into the pleural space and causes
TB empyema (pus in the pleural fluid).
10.
11. Miliary TB
Miliary TB is disseminated TB. "Miliary" describes the appearance
on chest x-ray of very small nodules throughout the lungs that
look like millet seeds. Miliary TB can occur shortly after primary
infection. The patient becomes acutely ill with high fever and is in
danger of dying. The disease also may lead to chronic illness and
slow decline.
Symptoms may include fever, night sweats, and weight loss. It
can be difficult to diagnose because the initial chest x-ray may be
normal. Patients who are immunosuppressed and children who
have been exposed to the bacteria are at high risk for developing
miliary TB.
12.
13. Laryngeal TB
TB can infect the larynx, or the vocal chord
area. It is extremely infectious.
14.
15. Extrapulmonary Tuberculosis
This type of tuberculosis occurs primarily
in immunocompromised patients.
Lymph Node Disease
Tuberculosis Peritonitis
Tuberculosis Pericarditis
Osteal Tuberculosis
Renal Tuberculosis
Adrenal Tuberculosis
Tuberculosis Meningitis
16. Lymph Node Disease
Lymph nodes contain macrophages that capture the bacteria. Any
lymph node can harbor uncontrolled replication of bacteria,
causing the lymph node to become enlarged. The infection can
develop a fistula (passageway) from the lymph node to the skin.
Tuberculosis Peritonitis
M. tuberculosis can involve the outer linings of the intestines and
the linings inside the abdominal wall, producing increased fluid, as
in tuberculosis pleuritis. Increased fluid leads to abdominal
distention and pain. Patients are moderately ill and have fever.
17.
18. Tuberculosis Pericarditis
The membrane surrounding the heart (the pericardium) is
affected in this condition. This causes the space between the
pericardium and the heart to fill with fluid, impeding the heart's
ability to fill with blood and beat efficiently.
Osteal Tuberculosis
Infection of any bone can occur, but one of the most common
sites is the spine. Spinal infection can lead to compression
fractures and deformity of the back.
Renal Tuberculosis
This can cause asymptomatic pyuria (white blood cells in the
urine) and can spread to the reproductive organs and affect
reproduction. In men, epididymitis (inflammation of the
epididymis) may occur.
19.
20. Adrenal Tuberculosis
TB of the adrenal glands can lead to adrenal
insufficiency. Adrenal insufficiency is the inability to
increase steroid production in times of stress, causing
weakness and collapse.
TB Meningitis
M. tuberculosis can infect the meninges (the
mainmembrane surrounding the brain and spinal cord).
This can be devastating, leading to permanent
impairment and death. TB can be difficult to discern
from a brain tumor because it may present as a focal
mass in the brain with focal neurological signs.
Headache, sleepiness, and coma are typical symptoms.
The patient may appear to have had a stroke.
21.
22. Signs and symptoms
Tuberculosis may infect any part of the body, but most
commonly occurs in the lungs (known as pulmonary
tuberculosis). Extrapulmonary TB occurs when
tuberculosis develops outside of the lungs, although
extrapulmonary TB may coexist with pulmonary TB, as
well.
General signs and symptoms include fever, chills, night
sweats, loss of appetite, weight loss,
and fatigue. Significant nail clubbing may also occur.
23.
24. Causes
The main cause of TB is Mycobacterium tuberculosis, a
small, aerobic, nonmotile bacillus.[10] The
high lipid content of this pathogen accounts for many of
its unique clinical characteristics.[19] It divides every 16
to 20 hours, which is an extremely slow rate compared
with other bacteria, which usually divide in less than an
hour.[20] Mycobacteria have an outer membrane lipid
bilayer.
MTB can withstand weak disinfectants and survive in
a dry state for weeks. In nature, the bacterium can
grow only within the cells of a host organism, but M.
tuberculosis can be cultured in the laboratory
25.
26. Methods of prophylaxis
Stopping the Spread of Tuberculosis
Anyone who comes into contact with an individual infected with
tuberculosis bacteria is at risk of developing the disease, so one
obvious solution is to steer clear of people who are sick, sneezing, and
coughing. Follow these additional steps to help prevent the spread of
tuberculosis infection:
People with tuberculosis infection should always cover their mouths
when they cough or noses when they sneeze.
People with latent tuberculosis infection — when there are
no symptoms or active disease — should take medication to prevent it
from becoming active tuberculosis disease.
People with TB should take all medications as required.
People at risk for or who have been in contact with people with
tuberculosis infection should be tested.
27. The TB Vaccine
The vaccine, developed nearly 100 years ago, is called BCG
(bacille Calmette-Guérin). It is made from weakened tuberculosis
bacteria that infect cows, similar to the human form of
tuberculosis.
The vaccine works against a severe type of TB that affects young
children, but it is not effective against the type of bacteria found
in adults. That severe type of tuberculosis, called military TB , is
rare in the United States, so the vaccine isn’t used on young
children here.
Children who live with someone infected with TB may be eligible
to receive the vaccine if they would not be able to tolerate the
antibiotic treatment or if the type of TB is antibiotic-resistant.
28. TB Testing
Anyone who has been or may have been exposed to
tuberculosis should be tested for it right away. The sooner TB
is diagnosed, the sooner treatment can begin — and the easier
it is to prevent both its spread and serious complications.
A simple skin test, known as the PPD (purified protein
derivative) TB skin test or tuberculin skin test, is given to
check for the presence of the bacteria that cause tuberculosis.
A chemical is injected just beneath the skin surface, and
within 48 to 72 hours the skin is examined for any reaction.
Swelling may indicate a positive test result.
29.
30. Tuberculosis Medication
Medications are available to treat active tuberculosis, as
well as to prevent latent tuberculosis infection from
developing into the actual disease. Isoniazid (INH), for
instance, is a drug prescribed for those with latent
tuberculosis infection.
Medications must be started right away to control the
disease and keep it from infecting other people. They
are typically taken several times a day for at least six
months, and sometimes up to a year.
31. Protect your family and friends
If you have active TB, keep your germs to yourself. It generally takes a few
weeks of treatment with TB medications before you're not contagious
anymore. Follow these tips to help keep your friends and family from getting
sick:
Stay home. Don't go to work or school or sleep in a room with other people
during the first few weeks of treatment for active tuberculosis.
Ventilate the room. Tuberculosis germs spread more easily in small closed
spaces where air doesn't move. If it's not too cold outdoors, open the
windows and use a fan to blow indoor air outside.
Cover your mouth. Use a tissue to cover your mouth anytime you laugh,
sneeze or cough. Put the dirty tissue in a bag, seal it and throw it away.
Wear a mask. Wearing a surgical mask when you're around other people
during the first three weeks of treatment may help lessen the risk of
transmission.